← Back to Clinical Trials
Recruiting NCT07764380

NCT07764380 Epigenetic and Cortisol Level Reflections of Maternal Stress During Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07764380
Status Recruiting
Phase
Sponsor Kahramanmaras Sutcu Imam University
Condition Pregnancy
Study Type INTERVENTIONAL
Enrollment 140 participants
Start Date 2026-05-15
Primary Completion 2026-09-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 49 Years
Study Type INTERVENTIONAL
Interventions
Maternal Epigenetics Training Module

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 140 participants in total. It began in 2026-05-15 with a primary completion date of 2026-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to evaluate the effects of stress management and epigenetic awareness training provided in prenatal classes on maternal stress levels, cortisol levels, and epigenetic awareness. The main questions it aims to answer are: 1. Do stress management and epigenetic awareness training provided in prenatal classes affect pregnant women's cortisol levels? 2. Does the training affect pregnant women's knowledge and awareness of epigenetic effects?

Eligibility Criteria

Inclusion Criteria: * Pregnant women aged 18 and older * Pregnant women in any trimester of pregnancy * Pregnant women who can read and understand Turkish * Pregnant women who voluntarily agree to participate in the study * Having a singleton pregnancy * Pregnant women without a high-risk pregnancy * Pregnant women who voluntarily participate in prenatal education classes will be included. Exclusion Criteria: * Foreign nationals with communication difficulties, * Multiple pregnancies, * Illiterate pregnant women, * Migrant pregnant women who do not speak Turkish, * Pregnant women with high-risk pregnancies, * Pregnant women not enrolled in prenatal education programs, * Pregnant women with intellectual disabilities, * Pregnant women who refuse to participate in the study will be excluded.

Contact & Investigator

Central Contact

İsmail Gürkan Çıkım, Professor

✉ ismailgurkancikim@ksu.edu.tr

📞 (344) 310-0000

Principal Investigator

ESRA KARATAŞ OKYAY, PhD

STUDY CHAIR

Kahramanmaras Sutcu Imam University

Frequently Asked Questions

Who can join the NCT07764380 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 49 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07764380 currently recruiting?

Yes, NCT07764380 is actively recruiting participants. Contact the research team at ismailgurkancikim@ksu.edu.tr for enrollment information.

Where is the NCT07764380 trial being conducted?

This trial is being conducted at Kahramanmaraş, Turkey (Türkiye), Kahramanmaraş, Turkey (Türkiye).

Who is sponsoring the NCT07764380 clinical trial?

NCT07764380 is sponsored by Kahramanmaras Sutcu Imam University. The principal investigator is ESRA KARATAŞ OKYAY, PhD at Kahramanmaras Sutcu Imam University. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology